Cargando…
Identification of pyrvinium pamoate as an anti-tuberculosis agent in vitro and in vivo by SOSA approach amongst known drugs
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb) bacteria, is a leading infectious cause of mortality worldwide. The emergence of drug-resistant M. tb has made control of TB more difficult. The selective optimization of side activities (SOSA) approach uses old drugs for new pharmacolog...
Autores principales: | Guan, Qing, Zhan, Lingjun, Liu, Zhi-Hao, Pan, Qin, Chen, Xu-Lin, Xiao, Zhen, Qin, Chuan, Zhang, Xiao-Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034053/ https://www.ncbi.nlm.nih.gov/pubmed/32013776 http://dx.doi.org/10.1080/22221751.2020.1720527 |
Ejemplares similares
-
Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo
por: Li, Yali, et al.
Publicado: (2022) -
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
por: Gunderson, Emma L., et al.
Publicado: (2022) -
Synergistic Effect of Pyrvinium Pamoate and Azoles Against Aspergillus fumigatus in vitro and in vivo
por: Sun, Yi, et al.
Publicado: (2020) -
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013) -
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
por: Schultz, Christopher W., et al.
Publicado: (2022)